Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Ticking Time Bombs: 3 Dow Stocks to Dump While You Still Can
03:00pm, Wednesday, 01'st May 2024
Here are three prominent Dow stocks facing challenges that every investor should be aware of. Even with any business's challenges, savvy investors can identify possible openings for strategic position
Moody's, Booking, DraftKings, Amgen stocks in focus ahead of earnings
11:08am, Wednesday, 01'st May 2024
American stocks were mixed on Wednesday as the earnings season continued and as investors waited for the latest Federal Reserve decision. The Dow Jones rose by over 65 points while the S&P 500 and Nas
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
12:21pm, Tuesday, 30'th Apr 2024
Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.
Sandoz reaches agreement with Amgen over patent dispute
01:51am, Tuesday, 30'th Apr 2024
Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. drugmaker Amgen resolving all patent litigation related to its U.S. denosumab biosimilars.
AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS
04:00pm, Monday, 29'th Apr 2024
THOUSAND OAKS, Calif. , April 29, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the close of the
What's in the Cards for Amgen (AMGN) This Earnings Season?
01:36pm, Monday, 29'th Apr 2024
Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics
10:22am, Monday, 29'th Apr 2024
Get a deeper insight into the potential performance of Amgen (AMGN) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some o
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
01:06pm, Wednesday, 24'th Apr 2024
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline
FTC looking to accelerate inquiry into prescription-drug middlemen, chair says
01:06pm, Tuesday, 23'rd Apr 2024
The Federal Trade Commission is working to accelerate its inquiry into the prescription-drug middlemen known as pharmacy-benefit managers, while also expanding its scrutiny of drug patents that can ke
Goldman Sachs Has 6 Dividend Blue Chips on Its Conviction List of Top Stocks
08:00am, Tuesday, 23'rd Apr 2024
Sponsored: Find a Qualified Financial Advisor Finding a qualified financial advisor doesn't have to be hard.
Why Amgen (AMGN) Outpaced the Stock Market Today
06:56pm, Monday, 22'nd Apr 2024
In the most recent trading session, Amgen (AMGN) closed at $271.48, indicating a +0.95% shift from the previous trading day.
The Dividend Goldmine: 3 Shining Stocks With Growing Payouts
07:14am, Friday, 19'th Apr 2024
There is always a constant search for dependable prospects that offer stability and advancement. In the middle of this hunt, dividend stocks with growth stand out as possible bright spots that give i
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
07:06pm, Wednesday, 17'th Apr 2024
Amgen (AMGN) concluded the recent trading session at $264.07, signifying a -0.59% move from its prior day's close.
This biotech high-dividend stock is beating S&P 500
08:52am, Wednesday, 17'th Apr 2024
Dividend investing can be a profitable strategy for traders, providing an extra source of income alongside potential stock gains. Amgen (NASDAQ: AMGN) has demonstrated strong performance, surpassing t
Can This High-Yield Dividend Stock Keep Beating the S&P 500?
07:30am, Wednesday, 17'th Apr 2024
Amgen, a leading U.S. biotech company, has outperformed the S&P 500 since 2011. However, the biotech's shares have struggled in 2024.
